DEVELOP

International strategy

An action strategy for the firm’s development and the territory’s attractiveness

The area of Life Sciences, as all sectors of so-called high-technology, is characterized by a world-wide market. In fact, the biotech companies are quickly brought to cross borders to identify the right partners to enable them to ensure their development and growth.

Lyonbiopole therefore, as part of its support to international, offers its encouragement to SMBs in the development of strategic partnerships and that, going fom scientific technology partnership to co-development or co-marketing partnership.

The goal is simple, encouraging business’ growth, whether scientific point of view through the emergence of new collaborative R&D projects, as the technological point of view through the establishment of partnerships or joint development yet the business perspective by signing a contract with a client.

Lyonbiopole does not stop there and establishes its own agreements with partner clusters. Once again, the objectives are multiple:
> The exchange of good practices and information between clusters and the implementation of joint
> Visibility and recognition in the international division
> The use of partner clusters as a gateway for our SMEs on foreign markets.

An international development focused on the main global markets

Europe
In just a few years, Lyonbiopole has managed to integrate into European networks and has developed many partnerships:
> Alps Bio Cluster project (Interreg project – Alpine Space)
> Italy - Piedmont: partnership agreements with BiPCa / bioPmed
> Israel: collaboration with Matimop
> Belgium: Collaboration with BioWin – Wallonia’s cluster
> Thematic network on medical systemic approaches in partnership with Stockholm, Munich, Amsterdam, Leicester, Luxembourg
More information

Outside Europe/International
Lyonbiopôle does not stop at Europe's borders and collaborate with many partners around the world:
> United States: Boston (MA), San Diego / SF (CA), Baltimore (MD)
> Japan, Kansai: A collaboration agreement with KBCP under the CFL
> Canada (Quebec): A collaboration agreement with the CQVB in the CFL
> China, Shanghai: Technological cooperation and higher education projects, a LIFE hustle and bustle
More information


Lyonbiopole’s Toolbox for corporate support in the International

Beyond and in addition to partnerships established throughout the world, Lyonbiopole develops tools and actions to support companies in their international steps and ensuring a profile of skills and expertise present in the region and French territory.

The International Technology Partnership Program (PPTI)
The PPTI is a program to support the international development of SME cluster members by encouraging them in setting up technological cooperation with European and international partners. In the past 3 years, Lyonbiopole has been supporting 45 companies in their international development.
More information
This program is made with two other French clusters : Alsace Bio-Valley and Cancer-Bio-Santé. This cooperation has resulted in the creation of Lifescience Corridor France (LCF) in December 2007.
More information


The events of international linkages
In recent years, Lyonbiopole managed to strengthen its presence abroad, notably by organizing business networking events of international scope:
> The “ French American Biotech Symposium”, FABS
> The “Fast-Track R&D Partnering with France” FTRD
> The “French American Scientific Track”, FAST
More information

 



They speak about...


« As part of its mission to support the economic development of SMBs, Lyonbiopole's staff is mobilized to ensure the success of this daylong event dedicated to funding. The event, which featured roundtable discussions and presentations, allowed for interactive dialog between the participants, the aim being to promote contacts between managers of SMBs and private and institutional investors. The strengthening of SMBs' equity is an essential condition to set up increasingly ambitious R&D projects, for their competitiveness worldwide and for their credibility in the eyes of major industrial groups. »


Thierry Abribat

Alizée Pharma - President

DOCUMENTATION | CONTACT | SEARCH